Fig. 2From: Are breast cancer patients with suboptimal adherence to cardiovascular treatment more likely to discontinue adjuvant endocrine therapy? Competing risk survival analysis in a nationwide cohort of postmenopausal womenCumulative incidence of AET discontinuation, death and cancer recurrence over 5Â yearsBack to article page